A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2011
At a glance
- Drugs Dexmecamylamine (Primary)
- Indications Anxiety disorders; Depressive disorders
- Focus Adverse reactions
- 25 Jul 2011 Status changed from not yet recruiting to recruiting.
- 15 Jul 2011 New trial record